Cary J. Claiborne, MBA, is the founder and CEO of Prosperity Capital Management, LLC, a Private Investment and Advisory firm. His career spans over 35 years in the Finance, Pharma and Biotech industries.
Mr. Claiborne previously served as the Chief Financial Officer and member of the Board of Directors at Indivior PLC (INDV, FTSE 500), a specialty pharmaceutical company. Cary joined Indivior to lead the company’s demerger/spin off from its then parent company, Reckitt Benckiser. He brought his extensive public company leadership experience to the demerger process and the successful establishment of Indivior PLC as a separate, independent, listed company.
Prior to joining Indivior, Mr. Claiborne had been the CFO of Sucampo Pharmaceuticals (NASDAQ: SCMP), President, CEO, and a member of the board of directors of New Generation Biofuels, Inc., a NASDAQ (NGBF), as well as its CFO since 2007 and CFO of Osiris Therapeutics (NASDAQ: OSIR) leading the company’s initial public offering in 2006. Mr. Claiborne was also a member of the board of directors of MedicAlert Foundation from 2013-2016, where he served as the Chairman of their Audit & Finance Committees. Mr. Claiborne was a Vice-President Financial Planning & Analysis at Constellation Energy Group, The Home Depot, Inc., and MCI Corporation. He spent the first 15 years of his career in a series of progressively more responsible positions in financial management and senior management at GE Capital and GE since 1982. Mr. Claiborne received his MBA from Villanova University and his BA from Rutgers University.